New delivery approaches for pediatric brain tumors

Journal of Neuro-Oncology

Volumn 75, Issue 3, 2005, Pages 315-326

  Pollack, Ian F ^a   Keating, Robert ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Chemotherapy; Convection enhanced delivery; Glioma; Local delivery

Indexed keywords

CARMUSTINE; COPOLYMER; IL13 PE38QQR; IMMUNOTOXIN; POLYMER; PROPANE; SEBACIC ACID; T 38; TF CRM107; TP 38; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CHILDHOOD CANCER; CLINICAL TRIAL; DISEASE CONTROL; DISEASE COURSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MECHANISM; DRUG TARGETING; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; NONHUMAN; PROGNOSIS; REVIEW; TREATMENT FAILURE; TUMOR LOCALIZATION;

ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHILD; DELAYED-ACTION PREPARATIONS; DISEASE PROGRESSION; DRUG DELIVERY SYSTEMS; HUMANS; IMMUNOTOXINS; POLYMERS;

EID: 29644447114     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-6763-7     Document Type: Review

References (136)

1. JL Finlay JM Boyett AJ Yates et al. 1995 Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the Eight-Drugs-in-1-Day regimen J Clin Oncol 13 1 112-123 7799011 1:STN:280:ByqD1MnptlI%3D
2. JH Wisoff JM Boyett MS Berger C Brant H Li AJ Yates P McGuire-Cullen PA Turski LN Sutton JC Allen RJ Packer JL Finlay 1998 Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: A report of the Children's Cancer Group trial no. CCG-945 J Neurosurg 89 52-59 9647172 1:STN:280:DyaK1czgvFertQ%3D%3D
3. R Sposto IJ Ertel RDT Jenkin 1989 The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: Results of a randomized trial J Neuro-Oncol 7 165-177 1:STN:280:BiaA1c7nvFw%3D
4. IF Pollack JM Boyett AJ Yates PC Burger FH Gilles RL Davis JL Finlay 2003 The influence of central review on outcome associations in childhood malignant gliomas: Results from the CCG-945 experience Neuro-Oncology 5 197-207 10.1215/S1152851703000097 12816726
5. E Arenson J Ater J Bank H Bevan J Bruner P Cullen M Deutsch E Holmes T Luerssen R O'Brien N Shah R Sposto P Steinbok J Strain J Thomson A Yates 1999 A randomized phase II trial of high dose alkylating agents plus VP-16 in children with high grade astrocytoma J Pediatr Hematol Oncol 21 32510.1097/00043426-199907000-00085
6. DR Groothius 2000 The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery Neuro-Oncology 2 45-59
7. E Sipos B Tyler S Piantadosi P Burger H Brem 1997 Optimizing interstitial delivery of BCNU from controlled release polymers for the treatment of brain tumors Cancer Chemother Pharmacol 39 383-389 10.1007/ s002800050588 9054951 1:CAS:528:DyaK2sXis1ajsb8%3D
8. C Wang J Li CS T Teo Lee 1999 The delivery of BCNU to brain tumors J Controlled Release 61 21-41 10.1016/S0168-3659(99)00098-X 1:CAS:528:DyaK1MXlsFOku74%3D
9. LK Fung M Shin B Tyler H Brem M Saltzman 1996 Chemotherapeutic drugs released from polymers: Distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea in the rat brain Pharm Res 13 671-682 10.1023/A:1016083113123 8860421 1:CAS:528:DyaK28XivFaqurg%3D
10. H Brem S Piantadosi P Burger et al. 1995 Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas Lancet 345 1008-1012 10.1016/S0140-6736(95)90755-6 7723496 1:STN:280:ByqB2c%2FisVU%3D
11. S Valtonen U Timonen P Toivanen et al. 1997 Interstitial chemotherapy with carmustine-loaded polymers for high grade gliomas - a randomized, double-blind study Neurosurgery 1 44-49
12. H Brem M Ewend S Piantadosi et al. 1995 The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trial J Neuro-oncol 26 111-123 1:STN:280:BymA2sbosVQ%3D
13. M Westphal P Delavault D Hilt R Olivares V Belin C Daumas-Duport 2000 Placebo controlled double-blind randomized prospective phase III trial of local chemotherapy with biodegradable carmustine implants (GLIADEL™) in 240 patients with malignant gliomas: Final results Neuro-oncology 3 301
14. AB Pegg 1990 Mammalian O6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents Cancer Res 50 6119-6129 2205376 1:CAS:528:DyaK3cXmtVOisLs%3D
15. MS Bobola MS Berger JR Silber 1995 Contribution of O6-methylguanine-DNA methyltransferase to resistance to 1,3-(2-chloroethyl)-1-nitrosourea in human brain tumor-derived cell lines Mol Carcinogen 13 81-88 1:CAS:528:DyaK2MXmsl2rsbk%3D
16. TP Brent PJ Houghton JA Houghton 1985 O6-a1ky1guanine-DNA alky1transferase activity correlates with the therapeutic response of human rhabdomyosarcoma xenografts to 1-(2-chloroethyl)-3-trans-(4-methylcyclohexyl)-1-nitrosourea Proc Natl Acad Sci USA 82 2985-2989 3857628 1:CAS:528:DyaL2MXitFCktbw%3D
17. C Fujio HR Chang T Tsujimura K Ishizaki H Kitamura M Ikenage 1989 Hypersensitivity of human tumor xenografts lacking O6-alkylguanine-DNA alkyltransferase to the anti-tumor agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea Carcinogenesis (Lond.) 10 351-356 1:CAS:528:DyaL1MXht1yhs7s%3D
18. JR Silber BA Mueller TG Ewers MS Berger 1993 Comparison of O6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain Cancer Res 53 3416-3420 8324751 1:CAS:528:DyaK3sXmtVSrsr8%3D
19. S Hongeng TP Brent RA Sanford H Li LE Kun RL Heideman 1997 O6-methylguanine-DNA methyltransferase protein levels in pediatric brain tumors Clin Canc Res 3 2459-2463 1:STN:280:DyaK1M7htFajtw%3D%3D
20. SC Schold Jr TP Brent E Hofe von HS Friedman S Mitra DD Bigner JA Swenberg P Kleihues 1989 O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain tumor xenografts J Neurosurg 70 573-577 2926498
21. M Belanich M Pastor T Randall et al. 1996 Retrospective study of the correlation between DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine Cancer Res 56 783-788 8631014 1:CAS:528:DyaK28XhtVClsLc%3D
22. T Hotta Y Saito H Fujita et al. 1994 O6-alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications J Neuro-Oncol 21 135-140 10.1007/BF01052897 1:STN:280:ByqC28rhslM%3D
23. J Garcia-Foncillas E Andion SN Goodman OF Hidalgo V Vanaclocha SB Baylin JG Herman 2000 Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents NEJM 343 1350-1354 11070098
24. ME Dolan RB Mitchell C Mummert RC Moschel AB Pegg 1991 Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents Cancer Res 51 3367-3372 1647266 1:CAS:528:DyaK3MXkvVCrtr4%3D
25. SL Gerson E Zborowska K Norton NH Gordon JKV Willson 1993 Synergistic efficacy of O6-benzylguanine and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in a human colon cancer xenograft completely resistant to BCNU alone Biochem Pharmacol 45 483-491 10.1016/0006-2952(93)90086-C 8435098 1:CAS:528:DyaK3sXhs1Slu7c%3D
26. G Felker H Friedman E Dolan et al. 1993 Treatment of subcutaneous and intracranial brain tumor xenografts with O6-benzylguanine and BCNU Cancer Chemother Pharmacol 32 471-476 10.1007/BF00685892 8258196 1:CAS:528:DyaK2cXht1Cgs7o%3D
27. RB Mitchell RC Moschel ME Dolan 1992 Effect of O6-benzylguanine on the sensitivity of human tumor xenografts to 1,3-bis(2-choroethyl)-1-nitrosourea and on DNA interstrand cross-link formation Cancer Res 52 1171-1175 1737376 1:CAS:528:DyaK38Xhs1Gku78%3D
28. SR Wedge ES Newlands 1996 O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU Br J Cancer 73 1049-1052 8624262 1:CAS:528:DyaK28XjtlSiur4%3D
29. J Weingart E Dolan M Rosenblum S Tatter K Judy J Olson D Glass-Macenka et al. 2003 Phase I study of gliadel combined with a continuous intravenous infusion of O6-benzylguanine in patients with recurrent malignant glioma Neuro-Oncology 5 357
30. RI Haroun H Brem 2000 Local drug delivery Curr Opin Oncol 12 187-193 10.1097/00001622-200005000-00001 10841189 1:CAS:528:DC%2BD3cXot1WgtLo%3D
31. A Olivi J Bruce S Saris et al. 1998 Phase I study of escalating doses of interstitial BCNU administered via wafer in patients with recurrent malignant glioma Proc Am Soc Clin Oncol 17 387
32. LK Fung MG Ewend A Sills EP Sipos R Thompson M Watts et al. 1998 Pharmacokinetics of interstitial delivery of carmustine 4-hydroperoxycyclophosphamide, and paclitaxel from biodegradable polymer implant in the monkey brain Cancer Res 58 672-684 9485020 1:CAS:528:DyaK1cXht1antbY%3D
33. P Menei M Boisdron-Celle A Croue G Guy JP Benoit 1996 Effect of stereotactic implantation of biodegradable 5-fluorouracil-leaded microspheres in healthy and C6 glioma-bearing rats Neurosurgery 39 117-124 10.1097/00006123-199607000-00023 8805147 1:STN:280:BymA1MfjtVw%3D
34. P Menei MC Venier E Gamelin SP Saint-Andre G Hayek E Jadavol et al. 1999 Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma Cancer 86 324-329 10.1002/ (SICI)1097-0142(19990715)86:2<325::AID-CNCR17>3.0.CO;2-S
35. IF Pollack 1994 Brain tumors in children N Engl J Med 337 1500-1507
36. RH Bobo D Laske A Akbasak et al. 1994 Convection-enhanced delivery of macromolecules in the brain Proc Natl Acad Sci 91 2076-2080 8134351 1:CAS:528:DyaK2cXit1KktL4%3D
37. DM Lieberman DW Laske PF Morrison et al. 1995 Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion J Neurosurg 82 1021-1029 7539062 1:CAS:528:DyaK2MXmsVGmsL8%3D
38. DW Laske PF Morrison DM Lieberman et al. 1997 Chronic interstitial infusion of protein to primate brain: Determination of drug distribution and clearance with single-photon emission computerized tomography imaging J Neurosurg 87 586-594 9322847 1:CAS:528:DyaK2sXms12ntr4%3D
39. MY Chen RR Lonser PF Morrison et al. 1999 Variables affecting convection-enhanced delivery to the striatum: A systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time J Neurosurg 90 315-320 9950503 1:STN:280:DyaK1M7jsVSjsA%3D%3D
40. J Sampson G Akabani D Reardon RE Coleman H Friedman J Provenzale 2003 Imaging and predicting the extensive intracerebral distribution of macromolecules after direct infusion Neuro-Oncology 5 397
41. I Pastan D FitzGerald 1991 Recombinant toxins for cancer treatment Science 254 11731683495 1:CAS:528:DyaK38XjtlOkuw%3D%3D
42. L Greenfield VG Johnson RJ Youle 1987 Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity Science 238 536-539 3498987 1:CAS:528:DyaL1cXjtFCgug%3D%3D
43. VG Johnson C Wrobel D Wilson J Zovickian L Greenfield EH Oldfield R Youle 1989 Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasia J Neurosurg 70 240-248 2783608 1:STN:280:BiaC3M%2FktlE%3D
44. L Recht CO Torres TW Smith V Raso TW Griffin 1990 Transferrin receptor in normal and neoplastic brain tissue. Implications for brain tumor immunotherapy J Neurosurg 72 941-945 2159987 1:STN:280:By%2BB2M%2FkvV0%3D
45. M Weaver DW Laske 2003 Transferrin ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas J Neuro-Oncol 65 3-13 10.1023/A:1026246500788
46. VG Johnson D Wilson L Greenfield RJ Youle 1998 The role of diphtheria toxin receptor in cytosol translocation J Biol Chem 263 1295-1300
47. DW Laske O Ilercil A Akbasak RJ Youle EH Oldfield 1994 Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice J Neurosurg 80 520-526 8113865 1:CAS:528:DyaK2cXksV2ksrw%3D 520-526 8113865 1:CAS:528:DyaK2cXksV2ksrw%3D
48. LA Martell A Agrawal DA Ross KM Muraszko 1993 Efficacy of transferring receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors Cancer Res 53 1348-1353 8443815 1:CAS:528:DyaK3sXit1Gju7w%3D
49. DW Laske RJ Youle EH Oldfield 1997 Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors Nature Med 12 1362-1368
50. W Debinski NI Obiri I Pastan et al 1995 A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4 J Biol Chem 270 16775-16780 10.1074/jbc.270.15.8797 7622490 1:CAS:528:DyaK2MXmvFOktL8%3D
51. BH Joshi K Kawakami P Leland RK Puri 2002 Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: Differential sensitivity to chimeric fusion proteins comprises of interleukin-13 and a mutated form of Pseudomonas exotoxin Clin Cancer Res 8 1948-1956 12060640 1:CAS:528:DC%2BD38Xlt1Cru74%3D
52. W Debinski I Pastan 1994 An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxin Bioconj Chem 5 40-46 1:CAS:528:DyaK2cXmvV2nuw%3D%3D
53. W Debinski NI Obiri SK Powers et al. 1995 Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin Clin Cancer Res 1 1253-1258 9815919 1:CAS:528:DyaK28XjvF2htw%3D%3D
54. BH Joshi GE Plautz RK Puri 2000 Interleukin-13 Receptor α chain: A novel tumor-associated transmembrane protein in primary explants of human malignant gliomas Cancer Res 60 1168-1172 10728667 1:CAS:528:DC%2BD3cXhvFWrsLg%3D
55. W Debinski DM Gibo SW Hulet et al. 1999 Receptor for interleukin 13 is a marker and therapeutic target for human high grade gliomas Clin Cancer Res 5 985-990 10353730 1:CAS:528:DyaK1MXjslKltL8%3D
56. NI Obiri P Leland T Murata W Debinski RK Puri 1997 The IL13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor complex J Immunol 158 756-764 8992992 1:CAS:528:DyaK2sXmtFGlsA%3D%3D
57. SR Husain RK Puri 2003 Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: From bench to bedside J Neuro-Oncol 65 37-48 10.1023/A:1026242432647
58. SR Husain BJ Joshi RK Puri 2001 Interleukin-13 receptor as a unique target for anti-glioblastoma therapy Int J Cancer 92 168-175 10.1002/ 1097-0215(200102)9999:9999<::AID-IJC1182>3.0.CO;2-N 11291041 1:CAS:528:DC%2BD3MXivVKqtrc%3D
59. J Weingart S Tatter S Rosenfeld T Mikkelsen G Barnett J Fisher et al. 2003 Intratumoral convection-enhanced delivery of IL13-PEQQR cytotoxin for recurrent malignant glioma without planned resection: A phase I/II study Neuro-Oncology 5 357
60. J Weingart LC Strauss SA Grossman J Markert S Tatter JD Fisher et al. 2002 Phase I/II study: Intratumoral infusion of IL13-PEQQR cytotoxin for recurrent supratentorial malignant glioma Neuro-Oncology 4 379
61. S Kunwar M Prados S Chang F Lang K Aldape A Yung et al. 2003 Peritumoral convection-enhanced delivery of IL13-PEQQR in patients with recurrent malignant glioma - phase I interim results Neuro-Oncology 5 351
62. MD Prados FF Lang JW Sherman LC Strauss CK Fleming K Aldape et al. 2002 Convection-enhanced delivery (CED) by positive pressure infusion for intra-tumoral and peri-tumoral administration of IL13-PEQQR, a recombinant tumor-targeted cytotoxin in recurrent malignant glioma Neuro-Oncology 4 S78
63. S Kunwar MD Prados F Lang C Fleming D Croteau K Aldape et al. 2003 Intracerebral convection-enhanced delivery (CED) of IL13-PEQQR, a recombinant tumor-targeted cytotoxin, in recurrent malignant glioma. A phase I trial Neuro-Oncology 5 387
64. S Kunwar 2003 Convection-enhanced delivery of IL13-PEQQR for treatment of recurrent malignant glioma: Presentation of interim findings from ongoing phase 1 studies Acta Neurochirurg 88 105-111 1:STN:280:DC%2BD3svmvFertA%3D%3D
65. AJ Wong SH Bigner DD Bigner KW Kinzler SR Hamilton B Vogelstein 1987 Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification Proc Natl Acad Sci USA 84 6899-6903 3477813 1:CAS:528:DyaL1cXktVyq
66. TA Liberman N Razon AD Bartal et al. 1984 Expression of epidermal growth factor receptors in human brain tumors Cancer Res 44 753-760
67. PA Humphrey AJ Wong B Vogelstein HS Friedman MH Werner DD Bigner SH Bigner 1989 Amplification and expression of the epidermal growth factor receptor gene in human glioma xenografts Cancer Res 48 2231-2238
68. S Kunwar L Pai I Pastan 1993 Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells J Neurosurg 79 569-576 7692018 1:CAS:528:DyaK2cXitlGmsb4%3D
69. JH Sampson G Akabani GE Archer DD Bigner MS Berger AH Friedman et al. 2003 Progress report of a phase I study of the intracerebral microinfusion of a recombinant chimeric protein composed of transforming growth factor (TGF)-α and a mutated form of the Pseudomonas exotoxin termed PE-38 (TP-38) for the treatment of malignant brain tumors J Neuro-Oncol 65 27-35 10.1023/A:1026290315809
70. F Weber 2004 Preliminary results of a phase II study of TP-38 immunotoxin delivered by convection-enhanced delivery to patients with recurrent glioblastoma multiforme - report of the TP38 Study Group Neuro-Oncology 6 345
71. RK Puri P Leland RJ Kreitman I Pastan 1994 Human neurological cancer cells express interleukin-4 (IL-4) receptors which are targets for the cytotoxic effect of IL4-Pseudomonas exotoxin chimeric protein Int J Cancer 58 574-581 8056454 1:CAS:528:DyaK2cXmslOlu78%3D
72. BH Joshi P Leland A Asher RA Prayson F Varicchio RK Puri 2001 In situ expression of interleukin-4 receptors in human brain tumors and cytotoxicity of a recombinant interleukin-4 (IL-4) cytotoxin in primary glioblastoma cell cultures Cancer Res 61 8058-8061 11719427 1:CAS:528:DC%2BD3MXovVShsr4%3D
73. RJ Kreitman RK Puri I Pastan 1994 A circularly permutated recombinant interleukin-4 toxin with increased activity Proc Natl Acad Sci 91 6889-6893 8041715 1:CAS:528:DyaK2cXltVKgsb4%3D
74. RK Puri DS Hoon P Leland P Snoy RW Rand L Pastan RJ Kreitman 1996 Preclinical development of a recombinant toxin containing circularly permuted interleukin-4 and truncated Pseudomonas exotoxin for therapy of malignant astrocytoma Cancer Res 56 5631-5637 8971168 1:CAS:528:DyaK2sXislKh
75. K Kawakami M Kawakami P Leland RK Puri 2002 Internalization property of interleukin-4 receptor α-chain increases cytotoxic effect of interleukin-4 receptor-targeted cytotoxin in cancer cells Clin Cancer Res 8 258-266 11801567 1:CAS:528:DC%2BD38XhsVKls7o%3D
76. SR Husain N Behari RJ Kreitman I Pastan RK Puri 1998 Complete regression of established human glioblastoma tumor xenograft by interleukin-4 toxin therapy Cancer Res 58 3649-3653 9721874 1:CAS:528:DyaK1cXlsFajt7Y%3D
77. RW Rand RJ Kreitman N Patronas F Varrichio I Pastan RK Puri 2000 Advances in brief: Intratumoral administration of a recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma Clin Cancer Res 6 2157-2165 10873064 1:CAS:528:DC%2BD3cXksVGhsr8%3D
78. AL Asher F Weber R Bucholz M Berger M Prados J Bruce et al. 2001 Safety, tolerability and tumor response of IL4-toxin (NBI-3001) in patients with recurrent malignant glioma Neurosurgery 49 525 10.1097/ 00006123-200108000-00127
79. FW Weber F Floeth A Asher R Bucholz M Berger M Prados et al. 2003 Local convection-enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma Acta Neurochirurgica 88(Suppl) 93-103
80. E Rustamzadeh C Li S Doumbia WA Hall DA Vallera 2003 Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme J Neuro-Oncol 65 63-75 10.1023/A:1026238331739
81. T Mori T Abe Y Wakabayashi et al. 2000 Up-regulation of urokinase-type plasminogen activator and its receptor correlates with enhanced invasion activity of human glioma cells mediated by transforming growth factor-alpha or basic fibroblast growth factor J Neuro-Oncol 46 115-123 10.1023/A:1006339717748 1:STN:280:DC%2BD3M%2Fhs1Ontw%3D%3D
82. TA Olson D Mohanraj S Roy S Ramakrishnan 1997 Targeting the tumor vasculature: Inhibition of tumor growth by a vascular endothelial growth factor-toxin conjugate Int J Cancer 73 865-870 10.1002/ (SICI)1097-0215(19971210)73:6<865::AID-IJC17>3.0.CO;2-3 9399667 1:CAS:528:DyaK2sXnslOqs78%3D
83. Z Lidar Y Mardor T Jonas R Pfeffer M Faibel D Nass R Hadani Z Ram 2004 Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: A phase I/II clinical study J Neurosurg 100 472-479 15035283 1:CAS:528:DC%2BD2cXitlyms74%3D
84. R Saito JR Bringas TR McKnight MF Wendland C Mamot DC Drummond et al. 2004 Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging Cancer Res 64 2572-2579 15059914 1:CAS:528:DC%2BD2cXis1yjurY%3D
85. J Voges R Reszka A Gossman C Dittmar R Richter G Garlip et al. 2003 Imaging-guided convection-enhanced delivery and gene therapy of glioblastoma Ann Neurol 54 479-487 10.1002/ana.10688 14520660 1:CAS:528:DC%2BD3sXosFCksLg%3D
86. M Bredel IF Pollack RL Hamilton CJ James 1999 Epidermal growth factor receptor expression in gene amplification in high-grade non-brain stem gliomas of childhood Clinical Cancer Res 5 1786-1792 1:CAS:528:DyaK1MXltVCqt78%3D
87. S Sgouros JH Goldin AD Hockley et al. 1999 Intracranial volume change in childhood J Neurosurg 91 610-616 10507383 1:STN:280:DyaK1MvjsFaitQ%3D%3D
88. G Occhiogrosso MA Edgar DI Sandberg MM Souweidane 2003 Prolonged convection-enhanced delivery into rat brainstem Neurosurgery 52 388-393 12535369
89. RR Lonser S Walbridge K Garmestani JA Butman HA Walters AO Vortmeye et al. 2002 Successful and safe perfusion of the primate brainstem: In vivo magnetic resonance imaging of macromolecular distribution during infusion J Neurosurg 97 905-913 12405380
90. DI Sandberg MA Edgar MM Souweidane 2002 Convection-enhanced delivery into the rat brainstem J Neurosurg 96 885-891 12005396
91. TF Lui SB Tatter MC Willingham M Yang JJ Hu AE Frankel 2003 Growth factor receptor expression varies among high-grade glioma and normal brain: Epidermal growth factor receptor has excellent properties for interstitial fusion protein therapy Mol Cancer Ther 2 783-787
92. JA Williams S Roman-Goldstein JR Crossen A D'Agostino SA Dahlborg EA Neuwelt 1993 Pre-irradiation osmotic blood-brain barrier disruption plus combination chemotherapy in gliomas: Quantitation of tumor response to assess chemosensitivity Adv Exp Med Biol 331 273-284 8333343 1:STN:280:ByyA38rkvVY%3D
93. SA Dahlborg A Petrillo JR Crossen S Roman-Goldstein ND Doolittle KH Fuller EA Neuwelt 1998 The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery Cancer J Sci Am 4 110-124 9532413 1:STN:280:DyaK1c7ptlGrsw%3D%3D
94. TF Cloughesy KL Black YP Gobin K Farahani G Nelson P Villablanca F Kabbinavar et al. 1999 Intra-arterial Cereport (RMP-7) and carboplatin: a dose escalation study for recurrent malignant gliomas Neurosurgery 44 270-278 9932880 1:STN:280:DyaK1M7ivFKlsg%3D%3D
95. ND Doolittle LE Abrey WA Bleyer S Brem TP Davis P Dore-Duffy LR Drewes WA Hall JM Hoffman A Korfel R Martuza LL Muldoon D Peereboom DR Peterson SD Rabkin Q Smith GH Stevens EA Neuwelt 2005 New frontiers in translational research in neuro-oncology and the blood-brain barrier: report of the tenth annual Blood-Brain Barrier Disruption Consortium Meeting Clinical Cancer Res 11 421-428
96. ND Doolittle ME Miner WA Hall T Siegal E Jerome E Osztie LD McAllister JS Bubalo DF Kraemer D Fortin R Nixon LL Muldoon EA Neuwelt 2000 Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood-brain barrier for the treatment of patients with malignant brain tumors Cancer 88 637-647 10.1002/(SICI)1097-0142(20000201)88:3<637::AID-CNCR22>3.0.CO;2-Y 10649259 1:STN:280:DC%2BD3c7hsFeksg%3D%3D
97. D Reardon G Akabani A Friedman H Friedman J Herndon R McLendon et al. 2004 Phase II study of 131-Iodine-labeled anti-tenascin murine monoclonal antibody 81C6 (M81C6) administered to deliver a targeted radiation boost of 44 Gy to the surgically created cystic resection cavity perimeter in the treatment of patients with newly diagnosed primary and metastatic brain tumors Neuro-Oncology 6 38110.1215/ S1152851703000413
98. D Reardon G Akabani A Friedman H Friedman J Herndon R McLendon et al. 2003 Phase I trial results using Iodine 131-labeled human-mouse chimeric antitenascin monoclonal antibody 81C6 via surgically created resection cavities in the treatment of patients with malignant gliomas Neuro-Oncology 5 395
99. LW Brady C Miyamoto DV Woo M Rackover J Emrich H Bender S Dadparvar Z Steplewski H Koprowski P Black B Lazzaro S Nair T McCormack J Nieves M Morabito J Eshleman 1992 Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial Int J Radiat Oncol Biol Phys 22 225-230 1309204 1:STN:280:By2D2sfgsVQ%3D
100. LR Rogers JR Rock A Sills M Vogelbaum M Ewend E Shaw 2004 Final results of a phase II study of resection and Gliasite brachytherapy for a single brain metastases Neuro-Oncology 6 36310.1215/S1152851703000334
101. MW McDermott PH Gutin DA Larson PK Sneed 1990 Interstitial brachytherapy Neurosurg Clin N Am 1 801-824 2136171 1:STN:280:By2A3s%2Fmtlw%3D 2136171 1:STN:280:By2A3s%2Fmtlw%3D
102. C Gomez-Manzano C Balague R Alemany MG Lemoine P Mitlianga H Jiang A Khan M Alonso FF Lang CA Conrad TJ Liu BN Bekele WK Yung J Fueyo 2004 A novel E1A-E1B mutant adenovirus induces glioma regression in vivo Oncogene 23 1821-1828 10.1038/sj.onc.1207321 15014451 1:CAS:528:DC%2BD2cXhvFOhsrw%3D
103. GG Vecil FF Lang 2003 Clinical trials of adenoviruses in brain tumors: A review of Ad-p53 and oncolytic adenoviruses J Neuro-Oncol 65 237-246 10.1023/B:NEON.0000003653.45635.32
104. AC Shah D Benos GY Gillespie JM Markert 2003 Oncolytic viruses: Clinical applications as vectors for the treatment of malignant gliomas J Neuro-Oncol 65 203-226 10.1023/B:NEON.0000003651.97832.6c
105. RJ Packer C Raffel JG Villablanca JC Tonn SE Burdach K Burger D LaFond JG McComb PH Cogen G Vezina LP Kapcala 2000 Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration J Neurosurg 92 249-254 10659011 1:CAS:528:DC%2BD3cXpvVagug%3D%3D
106. EH Oldfield Z Ram KW Culver et al. 1993 Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir Hum Gene Ther 4 39-69 8384892 1:STN:280:ByyB3MzptFU%3D
107. S Yoshida R Tanaka N Takai K Ono 1988 Local administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with malignant brain tumors Cancer Res 48 5011-5016 3261631 1:STN:280:BieA3M%2FoslQ%3D
108. D Barba SC Saris RN Holder SA Rosenberg EH Oldfield 1989 Intratumoral LAK cell and interleukin-2 therapy of human gliomas J Neurosurg 70 175-182 2643685 1:STN:280:BiaC3M%2Fkt1E%3D
109. M Bernstein NJ Laperriere 1990-1991 A critical appraisal of the role of brachytherapy for pediatric brain tumors Pediatr Neurosurg 16 213-218
110. IF Pollack LD Lunsford TL Slamovits et al. 1998 Stereotactic intracavitary irradiation for cystic craniopharyngiomas J Neurosurg 68 227-233
111. EO Backlund 1989 Colloidal radioisotopes as part of a multi-modality treatment of craniopharyngiomas J Neurosurg Sci 33 95-97 2674364 1:STN:280:BiaA1c7osVA%3D
112. EO Backlund B Axelsson CG Bergstrand et al. 1989 Treatment of craniopharygiomas - the stereotactic approach in a ten to twenty-three years perspective. I Surgical, radiological, and opthalmological aspects Acta Neurochir 99 11-19 10.1007/BF01407771 1:STN:280:BiaA3szjsl0%3D
113. TW Hood PE McKeever 1988 Stereotactic management of cystic gliomas of the brain stem Neurosurgery 24 373-378
114. J Fontanesi RL Heideman M Muhlbauer et al. 1995 High-activity 125-I interstitial irradiation in the treatment of pediatric central nervous system tumors: A pilot study Pediatr Neurosurg 22 289-298 7577662 1:STN:280:BymD2sngslw%3D
115. PJ Chuba L Zamarano M Hamre et al. 1998 Permanent I-125 brain stem implants in children Childs Nerv Syst 14 570-577 10.1007/s003810050274 9840381 1:STN:280:DyaK1M%2FlsVWitA%3D%3D
116. M Jansen PC Witt Hamer de AN Witmer 2004 Current perspective on antiangiogenesis strategies in the treatment of malignant gliomas Brain Res Brain Res Rev 45 143-163 10.1016/j.brainresrev.2004.03.001 15210301 1:CAS:528:DC%2BD2cXltVChu7s%3D
117. VK Puduvalli R Sawaya 2000 Antiangiogenesis - therapeutic strategies and clinical implications for brain tumors J Neuro-oncol 50 189-200 10.1023/ A:1006469830739 1:STN:280:DC%2BD3Mzmsl2ksw%3D%3D
118. RJ Packer 1999 Alternative treatments for childhood brain tumors Childs Nerv Syst 15 789-794 10.1007/s003810050472 10603024 1:STN:280:DC%2BD3c%2FmvFamsg%3D%3D
119. HA Fine 1995 Novel biologic therapies for malignant gliomas Antiangiogenesis, immunotherapy and gene therapy Neurol Clin 13 827-846 8583999 1:STN:280:BymC2Mjpt1U%3D
120. SA Im C Gomez-Manzano J Fueyo 1999 Antiangiogenesis treatment for gliomas: Transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo Cancer Res 59 895-900 10029081 1:CAS:528:DyaK1MXht1Siur0%3D
121. T Tanaka Y Manome P Wen 1997 Viral vector-mediated transduction of a modified platelet factor 4 cDNA inhibits angiogenesis and tumor growth Nat Med 3 437-442 10.1038/nm0497-437 9095178 1:CAS:528:DyaK2sXit1Ckurg%3D
122. G McBride 2002 Studies expand potential uses of photodynamic therapy J Natl Cancer Inst 94 1740-1742 12464643
123. MS Eljamel 2003 New light on the brain: The role of photosensitizing agents and laser light in the management of invasive intracranial tumors Technol Cancer Res Treat 2 303-309 12892512 1:CAS:528:DC%2BD3sXnsFCgsbs%3D
124. L Lilge BC Wilson 1998 Photodynamic therapy of intracranial tissues: A preclinical comparative study of four different photosensitizers J Clin Laser Med Surg 16 81-91 9663099 1:STN:280:DyaK1czislKjsw%3D%3D
125. B Olzowy CS Hundt S Stocker 2002 Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid J Neurosurg 97 970-976 12405389 1:CAS:528:DC%2BD38XosFehtb8%3D
126. SA Friesen GO Hjortland SJ Madsen 2002 5-aminolevulinic acid-based photodynamic detection and therapy of brain tumors (review) Int J Oncol 21 577-582 12168102 1:CAS:528:DC%2BD38Xmsl2jtro%3D
127. PJ Muller BC Wilson 1996 Photodynamic therapy for malignant newly diagnosed supratentorial gliomas J Clin Laser Med Surg 14 263-270 9612192 1:STN:280:DyaK1c3nsFWguw%3D%3D
128. MH Schmidt GA Meyer KW Reichert et al.: 2004 Evaluation of photodynamic therapy near functional brain tissue in patients with recurrent brain tumors J Neuro-oncol 67 201-207 10.1023/B:NEON.0000021804.50002.85
129. K Koshi Y Kinoshita H Imada et al.: 1999 Effects of radiotherapy after hyperbaric oxygenation on malignant gliomas Br J Cancer 80 236-241
130. CH Chang 1977 Hyperbaric oxygen and radiation therapy in the management of glioblastoma Natl Cancer Inst Monogr 46 163-169 206835 1:STN:280:CSeC2sjhsFc%3D
131. K Ogawa Y Yoshii O Inoue et al.: 2003 Prospective trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas Radiother Oncol 67 63-67 10.1016/S0167-8140(02)00406-1 12758241
132. K Morita R Tanaka K Kakinuma et al.: 2003 Combination therapy of rat brain tumors using localized interstitial hyperthermia and intra-arterial chemotherapy Int J Hyperthermia 19 204-212 10.1080/ 02656730210147295 12623642 1:CAS:528:DC%2BD3sXitVCmsr0%3D
133. T Sakai I Fujishima K Sugiyama et al.: 1992 Interstitial laserthermia in neurosurgery J Clin Laser Med Surg 10 37-40 10149909 1:STN:280:By2K3c7ltlE%3D
134. PK Sneed PR Stauffer MW McDermott et al.: 1998 Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/-hyperthermia for glioblastoma multiforme Int J Radiat Oncol Biol Phys 40 287-295 10.1016/S0360-3016(97)00731-1 9457811 1:STN:280:DyaK1c7hs12ruw%3D%3D
135. MH Seegenschmiedt HJ Feldmann P Wust M Molls 1995 Hyperthermia - its actual role in radiation oncology. Part IV: Thermo-radiotherapy for malignant brain tumors Strahlenther Onkol 171 560-572 8571175
136. K Kakinuma R Tanaka H Takahashi et al.: 1996 Drug delivery to the brain using thermosensitive liposome and local hyperthermia Int J Hyperthermia 12 157-165 8676003 1:CAS:528:DyaK28Xis1Ojurc%3D